Wealth Invest AKL AlphaCura 0/50/100 W
Wealth Invest AKL AlphaCura 0/50/100 W operates in various business sectors.
Market Cap & Net Worth: Wealth Invest AKL AlphaCura 0/50/100 W (WEIACW)
Wealth Invest AKL AlphaCura 0/50/100 W (CO:WEIACW) has a market capitalization of $143.69K (Dkr1.04 Million) as of March 19, 2026. Listed on the CO stock exchange, this Denmark-based company holds position #40249 globally and #311 in its home market, demonstrating a -1.15% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Wealth Invest AKL AlphaCura 0/50/100 W's stock price Dkr111.80 by its total outstanding shares 9338 (9.34K).
Wealth Invest AKL AlphaCura 0/50/100 W Market Cap History: 2025 to 2026
Wealth Invest AKL AlphaCura 0/50/100 W's market capitalization history from 2025 to 2026. Data shows growth from $142.34K to $143.69K (0.00% CAGR).
Wealth Invest AKL AlphaCura 0/50/100 W Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Wealth Invest AKL AlphaCura 0/50/100 W's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of WEIACW by Market Capitalization
Companies near Wealth Invest AKL AlphaCura 0/50/100 W in the global market cap rankings as of March 19, 2026.
Key companies related to Wealth Invest AKL AlphaCura 0/50/100 W by market ranking:
- LEIFHEIT (LEI.SG) (STU:LEI): Ranked #40240 globally with a market cap of $140.55K USD ( €136.93K EUR).
- Axon Partners Group S.A. (MC:APG): Ranked #40241 globally with a market cap of $140.55K USD ( €136.92K EUR).
- R STAHL N (BE:RSL2): Ranked #40250 globally with a market cap of $139.96K USD ( €136.35K EUR).
- Medivie Therapeutic Ltd (TA:MDVI): Ranked #40251 globally with a market cap of $139.96K USD ( ILA52.20 Million ILA).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #40240 | LEIFHEIT (LEI.SG) | STU:LEI | $140.55K | €14.95 |
| #40241 | Axon Partners Group S.A. | MC:APG | $140.55K | €15.20 |
| #40250 | R STAHL N | BE:RSL2 | $139.96K | €14.60 |
| #40251 | Medivie Therapeutic Ltd | TA:MDVI | $139.96K | ILA65.00 |
Wealth Invest AKL AlphaCura 0/50/100 W Historical Marketcap From 2025 to 2026
Between 2025 and today, Wealth Invest AKL AlphaCura 0/50/100 W's market cap moved from $142.34K to $ 143.69K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Dkr143.69K | +0.95% |
| 2025 | Dkr142.34K | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Wealth Invest AKL AlphaCura 0/50/100 W was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $143.69K USD |
| MoneyControl | $143.69K USD |
| MarketWatch | $143.69K USD |
| marketcap.company | $143.69K USD |
| Reuters | $143.69K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.